EventsTuesday, October 14, 2014
Niven Narain, Co-Founder, President and CTO, Berg
Dr. Niven Narain will be one of the six speakers for the Second BMCB-GGD Symposium, an event entirely organized and run by graduate students from the Fields of BMCB and GGD. He has wide connections and unique experiences and expertise in entrepreneurship & management, and will be able to share many of these with our students and postdocs. Niven Narain is not just a great scientist and entrepreneur, but he is also a mentor to many. He loves sharing with others his experiences and providing guidance and support to those who need it. Narain’s perseverance and audacity as a graduate student were key factors for his success; you will benefit a lot from listening to his story. At his company, he makes sure that his employees feel that they are part of a big family and that he gives them the opportunity to grow both as human beings and as scientists.
There will be multiple opportunities for graduate students and postdocs campus-wide to interact with Dr. Narain. Specifically,
Seminar on October 14th entitled "Biology: the real next frontier for discovering drugs, can we really make sense of all the data?": open to the entire Cornell community
FULL:Workshop on October 14th entitled "Science for the scientist: Industry vs Academia vs Government": exclusively open to graduate students but has limited seating (44 maximum)
FULL:Networking dinner on the evening of October 13th, limited to 10 students/postdocs in order to facilitate interaction between the participants and Dr. Narain. Open to BEST participants: contact Kelly Liu (firstname.lastname@example.org) to register in advance
NEW: Networking Breakfast 8-9am Tuesday, October 14, open exclusively to BEST participants at the Banfi restaurant at the Statler. Registration is limited and will be on a first-come first-serve basis. If you have any questions or if you would like to attend, please contact one of the student organizers, Madhura Raghavan at email@example.com. RSVP before Monday!
Niven R. Narain is Co-Founder, President & Chief Technology Officer of Berg, a Boston- based biopharma company that houses pharma, diagnostics, health analytics, and biosystems divisions. His primary research interest involves cancer metabolism and merging biology and machine learning (AI) technology to gain novel insight into differences in patient populations that contribute to disease. In addition, he is keenly interested in translating improved healthcare outcomes to improve the overall health economic impact. He is inventor of the Interrogative Biology™ platform that has produced and guided clinical development of lead molecules in cancer and diabetes. Notably, Narain is also co-discoverer of BPM 31510, currently in Phase Ib and IIb trials for solid tumors and skin cancer respectively. His technologies and scientific expertise is the subject of key collaborations within the US Department of Defense, Walter Reed National Military Medical Center, the National Institutes of Health, in addition to leading academic medical centers such as Harvard Medical School, MD Anderson Cancer Center, Weill Cornell Medical College, and the University of Miami Miller School of Medicine.
Narain has over 400 issued and pending US and international patents, covering novel biological platform technologies in addition to cancer, wound healing, burns, diabetes, diagnostic markers, metabolic diseases, and CNS diseases. Narain was previously Director of Cutaneous Oncology & Therapeutics Research at the Miller School of Medicine and serves as Sr. Biopharma Advisor to Ocean Tomo in Chicago. His research has been presented and published at major clinical and scientific meetings internationally and has been key in securing significant funding in both the academia and industry. A graduate of St. John's University in Biochemistry/Philosophy, Narain received his PhD training in cancer biology and clinical dermatology research at the Miller School of Medicine. Niven is a recipient of St. John's University's Charles Lacaillade Prize, the Sylvester Cancer Center Charles Gordon Zubrod Prize, and an NIH/NIDDK Award of Excellence.
He is a member of numerous international oncology and healthcare societies. His work in cancer and health analytics has been featured in Forbes, CNBC, Fox Business, Bloomberg, and RE/Code. He has been an invited speaker at Aspen Ideas Festival, in addition to major healthcare conferences such as Bloomberg, The Economist, Financial Times, and the World Intellectual Property Organization in Geneva. Narain remains active in leadership and community outreach, having served as a mentor to many high school, college, and graduate/medical students in the Intel, Upward Bound, and NIH Howard Hughes Medical Internship. He is most passionate in improving patient care and enabling increased access to the most innovative technologies in an effort to improve the healthcare ecosystem.